Miniaturized fiber-optic hybrid sensor for continuous glucose monitoring in subcutaneous tissue

2007 ◽  
Vol 122 (1) ◽  
pp. 60-68 ◽  
Author(s):  
Alen Pasic ◽  
Hans Koehler ◽  
Ingo Klimant ◽  
Lukas Schaupp
Keyword(s):  
Continuous Glucose Monitoring ◽  
Fiber Optic ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring

A label-free fiber-optic Turbidity Affinity Sensor (TAS) for continuous glucose monitoring

2014 ◽  
Vol 61 ◽  
pp. 280-284 ◽  
Author(s):  
Ralph Dutt-Ballerstadt ◽  
Colton Evans ◽  
Arun P. Pillai ◽  
Ashok Gowda
Keyword(s):  
Continuous Glucose Monitoring ◽  
Fiber Optic ◽  
Glucose Monitoring ◽  
Label Free

scholarly journals Acute Response in vivo of a Fiber-Optic Sensor for Continuous Glucose Monitoring from Canine Studies on Point Accuracy

Sensors ◽  
2010 ◽  
Vol 10 (8) ◽  
pp. 7789-7802 ◽  
Author(s):  
Kuo-Chih Liao ◽  
Shih-Chieh Chang ◽  
Cheng-Yang Chiu ◽  
Yu-Hsiang Chou
Keyword(s):  
Continuous Glucose Monitoring ◽  
Fiber Optic ◽  
Glucose Monitoring ◽  
Fiber Optic Sensor ◽  
Acute Response ◽  
Optic Sensor

Biocompatibility of an Electrochemical Sensor for Continuous Glucose Monitoring in Subcutaneous Tissue

2005 ◽  
Vol 7 (1) ◽  
pp. 163-173 ◽  
Author(s):  
A. Mang ◽  
J. Pill ◽  
N. Gretz ◽  
B. Kränzlin ◽  
H. Buck ◽  
...  
Keyword(s):  
Electrochemical Sensor ◽  
Continuous Glucose Monitoring ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring

scholarly journals Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems

2020 ◽  
Vol 15 (1) ◽  
pp. 167-173 ◽  
Author(s):  
Jeffrey I. Joseph
Keyword(s):  
Continuous Glucose Monitoring ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring ◽  
Clinical Trial Data ◽  
Diabetes Patient ◽  
Glucose Levels ◽  
Study Results ◽  
And Performance ◽  
Patient Use

The article published by Kevin Cowart in this issue of the Journal of Diabetes Science and Technology (JDST) is a detailed overview of the clinical trial data and analysis used to demonstrate the safety and effectiveness of the Eversense continuous glucose monitoring (CGM) System for regulatory approval and clinical acceptance. The article describes the published study results for safety, accuracy, reliability, ease of insertion/removal, adverse events, and ease of diabetes patient-use for controlling their glucose levels short and long term. The author nicely compares Eversense CGM System safety and performance with the short-term subcutaneous tissue CGM systems being commercialized by Dexcom, Medtronic Diabetes, and Abbott Diabetes. This comparison may help the clinician define which type of patient with diabetes might benefit the most from the long-term implantable CGM system. The majority of studied patients describe a positive experience managing their diabetes with the Eversense CGM System and request implantation of a new sensor 90 or 180 days later.

scholarly journals Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?

2018 ◽  
Vol 14 (2) ◽  
pp. 24 ◽  
Author(s):  
Lutz Heinemann ◽  
Andreas Stuhr
Keyword(s):  
Blood Glucose ◽  
Continuous Glucose Monitoring ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring ◽  
Relative Difference ◽  
Management Options ◽  
Measurement Quality ◽  
Glucose Levels ◽  
Wide Range ◽  
Patients With Diabetes

Monitoring glycaemic control in patients with diabetes has evolved dramatically over the past decades. The introduction of easy-to-use systems for self-monitoring of blood glucose (SMBG) utilising capillary blood samples has resulted in the availability of a wide range of systems, providing different measurement quality. Systems for continuous glucose monitoring (CGM) – used mainly in patients with type 1 diabetes (T1D) – were made possible by the development of glucose sensors that measure glucose levels in the interstitial fluid (ISF) in the subcutaneous tissue of the skin. CGM readings might not correspond exactly to SMBG measurement results taken at the same time, especially during rapid changes in either blood glucose or ISF glucose levels. The mean absolute relative difference is the most popular method used for characterising the measurement performance of CGM systems. Unlike the International Organization for Standardization 15197:2013 criteria for SMBG systems, no accuracy standards for CGM systems exist. Measurement quality of CGM systems can vary based on several factors, limiting their safety and effective use in managing diabetes. Patients have to be trained adequately to make safe and efficient use of CGM systems (like with SMBG systems). Also, systems for CGM must be evaluated in terms of patient safety and the ability to provide accurate measurements regardless of the fluctuation of glucose levels. As new technological advancements in glucose monitoring are essential for improved management options of diabetes, such as automated insulin dosing systems, there is a need for a critical view of all such developments. It is likely that both, SMBG and CGM systems, will play important future roles in the treatment of diabetes.

scholarly journals Glucose Sensing in the Subcutaneous Tissue: Attempting to Correlate the Immune Response with Continuous Glucose Monitoring Accuracy

2018 ◽  
Vol 20 (5) ◽  
pp. 321-324 ◽  
Author(s):  
Jeffrey I Joseph ◽  
Gabriella Eisler ◽  
David Diaz ◽  
Abdurizzagh Khalf ◽  
Channy Loeum ◽  
...  
Keyword(s):  
Immune Response ◽  
Continuous Glucose Monitoring ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring ◽  
Glucose Sensing ◽  
Monitoring Accuracy

scholarly journals Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue

Diabetologia ◽  
1992 ◽  
Vol 35 (3) ◽  
pp. 224-230 ◽  
Author(s):  
D. Moatti-Sirat ◽  
F. Capron ◽  
V. Poitout ◽  
G. Reach ◽  
D. S. Bindra ◽  
...  
Keyword(s):  
Continuous Glucose Monitoring ◽  
Glucose Sensor ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring ◽  
In Vivo Evaluation

Continuous Glucose Monitoring in Subcutaneous Tissue Using Factory-Calibrated Sensors: A Pilot Study

2010 ◽  
Vol 12 (8) ◽  
pp. 591-597 ◽  
Author(s):  
Udo Hoss ◽  
Iman Jeddi ◽  
Mark Schulz ◽  
Erwin Budiman ◽  
Claire Bhogal ◽  
...  
Keyword(s):  
Pilot Study ◽  
Continuous Glucose Monitoring ◽  
Subcutaneous Tissue ◽  
Glucose Monitoring

U-shaped fiber-optic ATR sensor enhanced by silver nanoparticles for continuous glucose monitoring

2015 ◽  
Vol 72 ◽  
pp. 370-375 ◽  
Author(s):  
Dachao Li ◽  
Songlin Yu ◽  
Changyue Sun ◽  
Chongwei Zou ◽  
Haixia Yu ◽  
...  
Keyword(s):  
Silver Nanoparticles ◽  
Continuous Glucose Monitoring ◽  
Fiber Optic ◽  
Glucose Monitoring
Sign in / Sign up

Export Citation Format

Share Document